ConductScience.org, home

Trial · NCT05908526

Outcomes11

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange in Daytime Insomnia Symptoms Scale (DISS)Baseline (start of study) and end of study (before day 16).Older adults with insomnia.units on a scaleMEAN
PRIMARYChange in Insomnia Severity as Assessed by Insomnia Severity IndexBaseline (start of study) and end of study (before day 16).Older adults with insomnia.units on a scaleMEAN
SECONDARYChange in Sleepiness as Assessed by Epworth Sleepiness ScaleBaseline (start of study) and end of study (before day 16).Older adults with insomniaunits on a scaleMEAN
SECONDARYChange in Depression as Assessed by Patient Health Questionnaire-9Baseline (start of study) and end of study (before day 16).Older adults with insomnia.units on a scaleMEAN
SECONDARYChange in Anxiety as Assessed by Generalized Anxiety Disorder-7Baseline (start of study) and end of study (before day 16).Older adults with insomnia.units on a scaleMEAN
SECONDARYChange in Cognitive Performance Assessed by the PVT (Psychomotor Vigilance Test): LapsesBaseline (start of study) and end of study (before day 16).Older adults with insomnia. Usable data was not available for ten participants (five in each treatment group).Lapses (reaction time >500 milliseconds)MEAN
SECONDARYChange in Cognitive Performance Assessed by the PVT (Psychomotor Vigilance Test): Median Reaction TimeBaseline (start of study) and end of study (before day 16).Older adults with insomnia. Usable data was not available for ten participants (five in each treatment group).Reaction Time (milliseconds)MEDIAN
SECONDARYChange in Cognitive Performance Assessed by the Stroop Test: AccuracyBaseline (start of study) and end of study (before day 16).Older adults with insomnia. Usable data was not available for ten participants (six in the treatment group and four in the placebo group).Number of ErrorsMEAN
SECONDARYChange in Cognitive Performance Assessed by the Stroop Test: Response Time in MillisecondsBaseline (start of study) and end of study (before day 16).Older adults with insomnia. Usable data was not available for ten participants (six in the treatment group and four in the placebo group).Response time in millisecondsMEAN
SECONDARYChange in Cognitive Performance Assessed by the Task-switching: Response Time in MillisecondsBaseline (start of study) and end of study (before day 16).Older adults with insomnia. Usable data was not available for six participants (three in each treatment group).Response Time (milliseconds)MEAN
SECONDARYChange in Cognitive Performance Assessed by the Task-switchingBaseline (start of study) and end of study (before day 16).Older adults with insomnia. Usable data was not available for six participants (three in each treatment group).Number of ErrorsMEAN

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05908526/outcomes